2025-05-09T13:29:27-05:00 2024-06-30 410746749 CLIFTONLARSONALLEN LLP 2021 SPRING ROAD SUITE 200 OAK BROOK IL 60523 990 2023-07-01 731386920 GATEWAY FOR CANCER RESEARCH GATE 8882212873 1449 S MICHIGAN AVE 13128 CHICAGO IL 60605 NATALIE STEWART PRESIDENT AND CEO 2246552409 2025-05-07 1 0 MELISSA STRUCK P01310867 6305738600 2025-05-06 2023 2025-03-06 01:10:19Z X NATALIE STEWART 1449 S MICHIGAN AVE 13128 CHICAGO IL 60605 13305231 0 X GATEWAYCR.ORG X 1991 OK TO FIND AND FUND CLINICAL CANCER RESEARCH. 12 12 11 23 0 0 12645682 11299095 75000 0 -65189 451037 -2184752 -2366606 10470741 9383526 6826886 6418187 0 0 1211507 1440538 0 0 1240988 1487195 769585 9525588 8628310 945153 755216 20261940 21075932 10138659 7946478 10123281 13129454 X TO ACCELERATE PRACTICE-CHANGING DISCOVERIES IN CANCER CARE BY HARNESSING THE UNRELENTING PASSION OF THE RESEARCH COMMUNITY AND EMPOWERING PATIENTS TO TRIUMPH OVER THEIR DISEASE. 0 0 6909315 6418187 GATEWAY FOR CANCER RESEARCH, A NON-PROFIT 501(C)(3) ORGANIZATION, WAS ESTABLISHED IN 1991 TO PROMOTE RESEARCH THAT MORE TRADITIONAL CANCER RESEARCH INSTITUTIONS MAY NOT FUND. GATEWAY IS DEDICATED TO ADVANCING INNOVATIONS IN THE SCIENTIFIC COMMUNITY AND SPEEDING THEM TO THE CANCER PATIENT'S BEDSIDE. THE WORK OF GATEWAY IS ABOUT GIVING CANCER PATIENTS THE ABILITY TO LIVE LONGER, MORE FULFILLING AND HEALTHIER LIVES.100% OF PUBLIC CONTRIBUTIONS RECEIVED ARE APPLIED DIRECTLY TO SUPPORT CANCER RESEARCH. OUR RESEARCH AND GRANTS COMMITTEE APPLIES STRINGENT GUIDELINES FOR REVIEWING EACH GRANT APPLICATION, RECOMMENDING TO THE BOARD OF DIRECTORS ONLY THOSE THAT ARE IN KEEPING WITH THE FOUNDATION'S MISSION. GATEWAY FOR CANCER RESEARCH RECEIVES FUNDING FROM A PRIVATE ENTITY UNDERWRITING ADMINISTRATIVE AND FUNDRAISING COSTS. THIS ALLOWS DONOR DOLLARS TO BE DIRECTED TO PATIENT-CENTERED RESEARCH. GATEWAY FOR CANCER RESEARCH IS CURRENTLY FUNDING 65 STUDIES. 6909315 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 21 0 11 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 12 12 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AZ CA CO CT FL IL ME MD MA MI MN MT MO NH NJ NY NC OH OK PA RI SC TN TX VA WA WI X X DIANE KINSLER 8882212873 1449 S MICHIGAN AVE SUITE 13128 CHICAGO IL 60605 FRED DEGRANDIS SECRETARY 0.30 X X 0 0 0 JOE CALTABIANO DIRECTOR 0.30 X 0 0 0 DENIZ RAZON DIRECTOR 0.30 X 0 0 0 RICHARD J STEPHENSON CHAIRMAN 0.30 X X 0 0 0 MARY LOU SMITH DIRECTOR 0.30 X 0 0 0 EDWIN ROBERSON DIRECTOR 0.30 X 0 0 0 TONY FESTA TREASURER 0.30 X X 0 0 0 STACIE J STEPHENSON VICE CHAIR 0.30 X X 0 0 0 SATISH TADIKONDA PHD DIRECTOR 0.30 X 0 0 0 TIMOTHY FLANIGAN ASST. SECRETARY 0.30 X X 0 0 0 TAWNYA BOND DIRECTOR 0.30 X 0 0 0 EMANUEL PETRICOIN PHD DIRECTOR 0.30 X 0 0 0 NATALIE STEWART PRESIDENT AND CEO 40.00 X 295180 0 0 DELORA SENFT CHIEF OPERATING OFFICER 40.00 X 174154 0 6594 NATALIA MIHILLI VP OF DEVELOPMENT 40.00 X 169282 0 8640 MALLORY MIDDLETON DIRECTOR OF ADVANCEMENT 40.00 X 104809 0 462 743425 0 15696 4 0 1 0 0 3235675 8063420 11299095 338130 338130 1583372 1470465 112907 112907 112907 84634 3235675 2451240 -2366606 -2366606 9383526 0 0 -1915569 6361861 6361861 56326 56326 556347 148915 148915 258517 622337 183216 5211 433910 128903 36398 14082 78423 132951 37471 17103 78377 73358 73358 116772 6480 94227 16065 278518 278518 12294 12294 90600 90600 4515 4515 MINOR EQUIPMENT AND SOF 69876 69876 BANK AND CREDIT CARD FE 33979 33979 RESEARCH AND GRANTS COM 28800 28800 LICENSES 6578 6578 54295 49848 4447 8628310 6909315 478007 1240988 4775562 1819259 804180 882524 701000 2775000 72711 37869 13399144 15178351 509343 382929 20261940 21075932 250794 273976 9862290 7650009 25575 22493 10138659 7946478 X 6565537 7294958 3557744 5834496 10123281 13129454 20261940 21075932 X 755216 1481785 769172 X X 0 1 X 1 0 X 5112519 3288310 9784782 12645682 11299095 42130388 5112519 3288310 9784782 12645682 11299095 42130388 17784658 24345730 386580 239499 270984 298338 338130 1533531 213907 95728 45176 78653 84634 518098 44182017 900000 0.55100 0.58960 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2021 AMOUNT: $ 3,056. SPECIAL EVENT REVENUE - 2019 AMOUNT: $ 213,907. 2020 AMOUNT: $ 95,728. 2021 AMOUNT: $ 42,120. 2022 AMOUNT: $ 78,653. 2023 AMOUNT: $ 84,634. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X PART X, LINE 2: THE FOUNDATION EVALUATES ITS EXPOSURE FOR UNCERTAIN TAX POSITIONS ON AN ANNUAL BASIS. AS OF JUNE 30, 2024 AND 2023, THERE WERE NO LIABILITIES RELATED TO UNCERTAIN TAX POSITIONS. 1 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS IN REGION GRANTS FOR CANCER RESEARCH 56326 0 0 0 0 0 0 56326 0 56326 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES CANCER RESEARCH 56326 WIRE 0 1 0 0 0 0 0 0 PART I, LINE 2: PROCEDURES ARE THE SAME AS DOMESTIC GRANTS. SEE SCHEDULE I. GALA 2849925 2814023 35902 35902 1628492 VINO 396036 347304 48732 48732 708335 1 74348 74348 29779 3320309 3235675 84634 84634 2366606 2451240 -2366606 1 BE THE MATCH FOUNDATION 500 N 5TH STREET MINNEAPOLIS MN 55401 411704734 501(C)(3) 200000 0 CANCER RESEARCH COLUMBIA UNIVERSITY IRVING MEDICAL CENTER 161 FORT WASHINGTON AVE NEW YORK NY 10032 135598093 501(C)(3) 275830 0 CANCER RESEARCH DUKE CANCER INSTITUTE 20 DUKE MEDICINE CIRCLE DURHAM NC 27710 560532129 501(C)(3) 93312 0 CANCER RESEARCH ICAHN SCHOOL OF MEDICINE MOUNT SINAI 1425 MADISON AVE 3RD FLOOR L3-17 NEW YORK NY 10029 136171197 501(C)(3) 247820 0 CANCER RESEARCH MASSACHUSETTS GENERAL HOSPITAL 13TH ST BLDG 149 ROOM 3219 CHARLESTOWN MA 02129 043230035 501(C)(3) 293658 0 CANCER RESEARCH MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 741587488 501(C)(3) 915855 0 CANCER RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131924236 501(C)(3) 296959 0 CANCER RESEARCH ST JUDE CHILDREN'S HOSPITAL 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 501(C)(3) 125000 0 CANCER RESEARCH THE ASCO FOUNDATION PO BOX 1455 CHARLOTTE NC 28201 311667995 501(C)(3) 57500 0 CANCER RESEARCH THE JOHN HOPKINS UNIVERSITY 400NCHARLES STREET BALTIMORE MD 21218 520595110 501(C)(3) 364322 0 CANCER RESEARCH THE LEUKEMIA & LYMPHOMA SOCIETY 3 INTERNATIONAL DRIVE SUITE 200 RYE BROOK NY 10573 135644916 501(C)(3) 500067 0 CANCER RESEARCH THE OHIO STATE UNIVERSITY JAMES CANCER HOSPITAL 300 W 10TH AVE COLUMBUS OH 43210 311301428 501(C)(3) 624012 0 CANCER RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 550 16TH STREET 4TH FLOOR SAN FRANCISCO CA 94158 943067788 501(C)(3) 413134 0 CANCER RESEARCH UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER 11100 EUCLID AVE CLEVELAND OH 44106 341567805 501(C)(3) 500000 0 CANCER RESEARCH UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 104 AIRPORT DRIVE SUITE 2200 CAMPUS BOX 1350 CHAPEL HILL NC 27599 566001393 501(C)(3) 176950 0 CANCER RESEARCH UNIVERSITY OF ROCHESTER 601 ELMWOOD ROCHESTER NY 55401 160743209 501(C)(3) 500000 0 CANCER RESEARCH WASHINGTON UNIVERSITY ST LOUIS 660 S EUCLID AVE ST LOUIS MO 63110 430653611 501(C)(3) 557687 0 CANCER RESEARCH YALE UNIVERSITY YALE CANCER CENTER 15 YORK STHRT 313D NEW HAVEN CT 06510 060646973 501(C)(3) 169755 0 CANCER RESEARCH DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02115 042263040 501(C)(3) 50000 0 CANCER RESEARCH 19 PART I, LINE 2: ALL GRANT APPLICATIONS MUST GO THROUGH A RIGOROUS PEER REVIEW PROCESS LED BY OUR RESEARCH AND GRANTS COMMITTEE - A DISTINGUISHED BOARD OF RENOWNED SCIENTISTS, PHYSICIANS, RESEARCHERS AND PATIENTS. THROUGH THIS PROCESS, SCIENTISTS INCLUDING EXPERTS IN A PARTICULAR AREA OF CANCER REVIEW AND EVALUATE APPLICATIONS AGAINST A CAREFULLY PRESCRIBED SET OF CRITERIA FOR JUDGING THE SCIENTIFIC MERIT AND POTENTIAL VALUE OF EACH PROPOSED STUDY. THIS REVIEW, NOT ONLY INCLUDES A NUMERICAL GRADING OF OBJECTIVE CRITERIA, IT ALSO INCLUDES A SUBJECTIVE COMMENTARY WITH SUGGESTED MODIFICATIONS. UPON RECOMMENDATION BY THE RESEARCH AND GRANTS COMMITTEE, THE APPLICATION IS SUBMITTED TO GATEWAY'S BOARD OF DIRECTORS FOR FUNDING CONSIDERATION. IF APPROVED AND FUNDED, GATEWAY GRANTEES SUBMIT REGULAR REPORTS (I.E., SEMI-ANNUALLY) TO THE RESEARCH GRANTS DEPARTMENT THAT SUMMARIZE THE PROGRESS OF THE FUNDED TRIAL ACCORDING TO THE PRINCIPAL INVESTIGATOR'S PROPOSED TIMELINE AND MILESTONES. ANNUALLY, THE RESEARCH GRANTS TEAM REVIEWS ALL REPORTS SUBMITTED WITHIN THE PAST YEAR AND ASSESSES WHETHER GRANTS ARE "ON TRACK OR "OFF TRACK", WITH RESPECT TO PATIENT ACCRUALS, TIMELY REPORTING, AND PROGRESS TOWARD MEETING STUDY MILESTONES. WHEN NEEDED, THE RESEARCH GRANTS TEAM CONSULTS WITH THE RESEACH AND GRANTS COMMITTEE TO REVIEW AND DEVELOP RECOMMENDATIONS FOR THE BOARD OF DIRECTORS ABOUT THOSE GRANTS THAT THEY DEEM "OFF TRACK". FUNDING CONTINUATION DECISIONS ARE CONTINGENT UPON GOOD PROGRESS/SPENDING. X X 0 0 0 0 0 0 0 0 0 NATALIE STEWART PRESIDENT AND CEO 224620 0 70560 0 0 0 0 0 0 0 295180 0 0 0 DELORA SENFT CHIEF OPERATING OFFICER 142154 0 32000 0 0 0 6594 0 0 0 180748 0 0 0 NATALIA MIHILLI VP OF DEVELOPMENT 147694 0 21588 0 0 0 8640 0 0 0 177922 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 BOARD MEMBERS RICHARD J STEPHENSON AND STACIE STEPHENSON ARE SPOUSES. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS FIRST REVIEWED BY THE ORGANIZATION'S INTERNAL STAFF AND A SUBSEQUENT REVIEW BY EXECUTIVE STAFF. THE FORM 990 IS THEN REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION'S BOARD MEMBERS AND STAFF ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY DURING A REGULARLY SCHEDULED BOARD MEETING AND DURING THE STAFF MEMBERS ANNUAL PERFORMANCE EVALUATION MEETING. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC VIA WEBSITE AND OTHER NONPROFIT PUBLICATIONS. FORM 990, PART XI, LINE 9: RETURN OF UNUSED GRANT FUNDS 769,172. FORM 990, PART XII, LINE 2C THE ORGANIZATION'S BOARD OF DIRECTORS ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. CELEBRITY FIGHT NIGHT FOUNDATION INC 2111 E HIGHLAND AVENUE STE 135 PHOENIX AZ 85016 860903119 FUNDRAISING FOUNDATION FOR NEUROGICAL RESEARCH AZ 501(C)(3) LINE 10 GATEWAY FOR CANCER RESEARCH 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0